So, the latest episode in the never-ending US tax and tariff saga has given the impression that ‘extend and pretend’ is now also a favourite theme in Washington. But I wouldn’t be so sure. The heat is ...

(Reuters) -U.S. President Donald Trump’s promised 50% copper tariffs are said to include all refined metal, Bloomberg reported on Friday, citing people familiar with the matter.

NEW YORK (Reuters) -Investors awaited tariff news between the U.S. and European Union on Friday that could add a potentially volatile development to the end of a week in which President Donald Trump ...

Codelco and Ecuadorean state miner Enami EP had in 2016 signed agreements to jointly develop the Llurimagua mining project in northern Ecuador, but Codelco in 2021 launched an arbitration process with ...

Investing.com -- Rolls-Royce (OTC: RYCEY) Corp. has been awarded a $54.7 million contract modification by the U.S. Department of Defense to produce engines for the U.S. Navy’s Ship to Shore Connector ...

Investing.com- President Donald Trump’s “big beautiful bill” has been hailed as the fiscal shot in the arm that could restore U.S. economic exceptionalism. But as the ink dries on this transformative ...

Investing.com -- Ultragenyx Pharmaceutical (TADAWUL: 2070) Inc. (NASDAQ: RARE) stock fell over 5% after the company announced that the U.S. Food and Drug Administration (FDA) has issued a Complete ...

Trump said late on Thursday the U.S. would impose a 35% tariff on Canadian imports next month and planned to impose blanket tariffs of 15% or 20% on most other trading partners.

(Reuters) -Apple has submitted a bid worth at least $150 million a year for the U.S. rights to stream Formula 1 races starting in 2026, Business Insider reported on Friday, citing a source familiar ...

According to two Canadian government officials cited by Politico, Ottawa will no longer proceed with plans to double its ...

PARIS (Reuters) -Brussels will propose a new tax on companies with a net turnover exceeding 50 million euros ($58.44 million) as part of an effort to generate new financing streams for the European ...

The published data showed that the combination of avutometinib plus defactinib demonstrated a confirmed overall response rate of 31% in all patients with recurrent low-grade serous ovarian cancer ...